Susquehanna International Group’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$389K Buy
46,851
+16,593
+55% +$138K ﹤0.01% 4677
2025
Q1
$184K Buy
30,258
+17,826
+143% +$109K ﹤0.01% 5564
2024
Q4
$78.6K Buy
+12,432
New +$78.6K ﹤0.01% 5752
2024
Q2
Sell
-22,599
Closed -$251K 5910
2024
Q1
$251K Buy
22,599
+7,559
+50% +$84.1K ﹤0.01% 4415
2023
Q4
$169K Buy
+15,040
New +$169K ﹤0.01% 5096
2023
Q3
Sell
-11,429
Closed -$101K 5802
2023
Q2
$101K Sell
11,429
-149,891
-93% -$1.32M ﹤0.01% 4998
2023
Q1
$1.34M Buy
161,320
+53,707
+50% +$447K ﹤0.01% 2484
2022
Q4
$1.03M Buy
+107,613
New +$1.03M ﹤0.01% 2296
2022
Q3
Sell
-49,075
Closed -$277K 6359
2022
Q2
$277K Sell
49,075
-84,889
-63% -$479K ﹤0.01% 4099
2022
Q1
$750K Sell
133,964
-137
-0.1% -$767 ﹤0.01% 3175
2021
Q4
$590K Buy
134,101
+107,159
+398% +$471K ﹤0.01% 3571
2021
Q3
$254K Buy
26,942
+12,544
+87% +$118K ﹤0.01% 4463
2021
Q2
$105K Buy
+14,398
New +$105K ﹤0.01% 5052
2021
Q1
Sell
-11,368
Closed -$85K 5344
2020
Q4
$85K Sell
11,368
-21,492
-65% -$161K ﹤0.01% 4531
2020
Q3
$199K Sell
32,860
-126,088
-79% -$764K ﹤0.01% 3891
2020
Q2
$1.33M Buy
158,948
+70,430
+80% +$588K ﹤0.01% 1842
2020
Q1
$526K Buy
88,518
+31,742
+56% +$189K ﹤0.01% 2825
2019
Q4
$368K Buy
56,776
+34,736
+158% +$225K ﹤0.01% 2962
2019
Q3
$106K Buy
+22,040
New +$106K ﹤0.01% 4069
2018
Q2
Sell
-56,707
Closed -$686K 3953
2018
Q1
$686K Buy
+56,707
New +$686K ﹤0.01% 1813